Fig. 3From: Nanomaterials: small particles show huge possibilities for cancer immunotherapyCopyright© 2020, copyright Chen et al.Anti-tumor efficacy of ORFT. A Schematic representation of the preparation and mechanism of action of ORFT derived from OMVs. B Tumor inhibitory rate (%) after treatments with ORFT et al. (mean ± SD, n = 5) C Survival rate of B16-F10 tumor-bearing mice after treatment with ORFT and other regimens. D Western blot analysis of cleaved caspase-3, Bcl-2 and HIF-lα protein expression in tumor tissues after receiving the corresponding treatments (***p < 0.001). Reprinted with permission from Ref. [99].Back to article page